Eco-Friendly Synthesis of 3-Aryl-2,3-dihydro-1,3,4-thiadiazoles Based on Benzofuran and Chromone Moieties

References

• C.-J. Li and B. M. Trost, “Green Chemistry for Chemical Synthesis,” Proceedings of the National Academy of Sciences of the United States of America 105, no. 36 (2008): 13197–202.
   PubMed Web of Science ®Google Scholar
• M. A. P. Martins, C. P. Frizzo, D. N. Moreira, L. Buriol, and P. Machado, “Solvent-Free Heterocyclic Synthesis,” Chemical Reviews 109, no. 9 (2009): 4140–82.
   PubMed Web of Science ®Google Scholar
• Y. Hu, C.-Y. Li, X.-M. Wang, Y.-H. Yang, and H.-L. Zhu, “1,3,4-Thiadiazole: Synthesis, Reactions, and Applications in Medicinal, Agricultural, and Materials Chemistry,” Chemical Reviews 114, no. 10 (2014): 5572–610. − 
   PubMed Web of Science ®Google Scholar
• S. Haider, M. S. Alam, and H. Hamid, “1,3,4-Thiadiazoles: A Potent Multi Targeted Pharmacological Scaffold,” European Journal of Medicinal Chemistry 92, (2015): 156–77.
   PubMed Web of Science ®Google Scholar
• A. Abdel-Aziem, “Synthesis and Antimicrobial Activity of Some Novel Thiazoles, 1,3,4-Thiadiazines, 1,3,4-Thiadiazoles Incorporating Coumarin Moiety,” Journal of Heterocyclic Chemistry 52, no. 1 (2015): 251–9.
   Web of Science ®Google Scholar
• G. Serban, O. Stanasel, E. Serban, and S. Bota, “2-Amino-1,3,4-Thiadiazole as a Potential Scaffold for Promising Antimicrobial Agents,” Drug Design, Development and Therapy 12, (2018): 1545–66.
   PubMed Web of Science ®Google Scholar
• Thoraya A. Farghaly, Magda A. Abdallah, and Mohamed R. Abdel Aziz, “Synthesis and Antimicrobial Activity of Some New 1,3,4-Thiadiazole Derivatives,” Molecules (Basel, Switzerland) 17, no. 12 (2012): 14625–36.
   PubMed Web of Science ®Google Scholar
• L.-J. Zhang, M.-Y. Yang, Z.-H. Sun, C.-X. Tan, J.-Q. Weng, H.-K. Wu, and X.-H. Liu, “Synthesis and Antifungal Activity of 1,3,4-Thiadiazole Derivatives Containing Pyridine Group,” Letters in Drug Design & Discovery 11, no. 9 (2014): 1107–11.
   Web of Science ®Google Scholar
• E. E. Oruç, S. Rollas, F. Kandemirli, N. Shvets, and A. S. Dimoglo, “1,3,4-Thiadiazole Derivatives. Synthesis, Structure Elucidation, and Structure-Antituberculosis Activity Relationship Investigation,” Journal of Medicinal Chemistry 47, no. 27 (2004): 6760–7.
   PubMed Web of Science ®Google Scholar
• K. Jakovljević, I. Z. Matić, T. Stanojković, A. Krivokuća, V. Marković, M. D. Joksović, N. Mihailović, M. Nićiforović, and L. Joksović, “Synthesis, Antioxidant and Antiproliferative Activities of 1,3,4-Thiadiazoles Derived from Phenolic Acids,” Bioorganic & Medicinal Chemistry Letters 27, no. 16 (2017): 3709–15.
   PubMed Web of Science ®Google Scholar
• J. Sainy, G. P. Mishra, R. Sharma, and S. C. Chaturvedi, “2-Amino-5-sulfanyl-1,3,4-thiadiazoles: A Novel Series of Anti-Inflammatory and Analgesic Agents,” Pharmaceutical Chemistry Journal 43 no. 1 (2009): 19–24.
   Web of Science ®Google Scholar
• S. Schenone, C. Brullo, O. Bruno, F. Bondavalli, A. Ranise, W. Filippelli, B. Rinaldi, A. Capuano, and G. Falcone, “New 1,3,4-Thiadiazole Derivatives Endowed with Analgesic and Anti-Inflammatory Activities,” Bioorganic & Medicinal Chemistry 14, no. 6 (2006): 1698–705.
   PubMed Web of Science ®Google Scholar
• Z. A. Mahmoud, G. S. Masaret, M. M. Amin, M. A. Abdallah, and T. A. Farghaly, “Anti-Inflammatory, Analgesic and Anti-Ulcerogenic Activities of Novel Bis-Thiadiazoles, Bis-Thiazoles and Bis-Formazanes,” Medicinal Chemistry 13, (2017): 226–38.
   PubMed Web of Science ®Google Scholar
• B. Sharma, A. Verma, S. Prajapati, and U. K. Sharma, “Synthetic Methods, Chemistry, and the Anticonvulsant Activity of Thiadiazoles,” International Journal of Medicinal Chemistry 2013, (2013): 348948.
   PubMedGoogle Scholar
• F. Clerici, D. Pocar, M. Guido, A. Loche, V. Perlini, and M. Brufani, “Synthesis of 2-Amino-5-sulfanyl-1,3,4-thiadiazole Derivatives and Evaluation of Their Antidepressant and Anxiolytic Activity,” Journal of Medicinal Chemistry 44, no. 6 (2001): 931–6.
   PubMed Web of Science ®Google Scholar
• S. Turner, M. Myers, B. Gadie, S. A. Hale, A. Horsley, A. J. Nelson, R. Pape, J. F. Saville, J. C. Doxey, and T. L. Berridge, “Antihypertensive Thiadiazoles. 2. Vasodilator Activity of Some 2-Aryl-5-guanidino-1,3,4-thiadiazoles,” Journal of Medicinal Chemistry 31, no. 5 (1988): 906–13.
   PubMed Web of Science ®Google Scholar
• A. B. Samel and N. R. Pai, “Synthesis of Novel Aryloxy Propanoyl Thiadiazoles as Potential Antihypertensive Agents,” Journal of the Chinese Chemical Society 57, no. 6 (2010): 1327–30.
   Google Scholar
• H. R. M. Rashdan, M. M. Farag, M. S. El-Gendey, and M. M. Mounier, “Toward Rational Design of Novel Anti-Cancer Drugs Based on Targeting, Solubility, and Bioavailability Exemplified by 1,3,4-Thiadiazole Derivatives Synthesized Under Solvent-Free Conditions,” Molecules 2019, no. 24 (2018): 2371–88.
   Google Scholar
• M. Juszczak, J. Matysiak, A. Niewiadomy, and W. Rzeski, “The Activity of a New 2-Amino-1,3,4-Thiadiazole Derivative 4ClABT in Cancer and Normal Cells,” Folia Histochemica et Cytobiologica 49, no. 3 (2011): 436–44.
   PubMed Web of Science ®Google Scholar
• T. A. Farghaly, M. A. Abdallah, and H. K. Mahmoud, “Synthesis of Novel 1,2,4-Triazoles and Triazolo-Thiadiazines as Anticancer Agents,” Turkish Journal of Chemistry 39, (2015): 955–69.
   Web of Science ®Google Scholar
• W. Rzeski, J. Matysiak, and M. Kandefer-Szerszeń, “Anticancer, Neuroprotective Activities and Computational Studies of 2-Amino-1,3,4-Thiadiazole Based Compound,” Bioorganic & Medicinal Chemistry 15, no. 9 (2007): 3201–7.
   PubMed Web of Science ®Google Scholar
• M. Juszczak, J. Matysiak, M. Szeliga, P. Pożarowski, A. Niewiadomy, J. Albrecht, and W. Rzeski, “2-Amino-1,3,4-thiadiazole Derivative (FABT) Inhibits the Extracellular Signal-Regulated Kinase Pathway and Induces Cell Cycle Arrest in Human Non-Small Lung Carcinoma Cells,” Bioorganic & Medicinal Chemistry Letters 22, no. 17 (2012): 5466–9.
   PubMed Web of Science ®Google Scholar
• W. S. Hamama, M. E. Ibrahim, H. A. Raoof, and H. H. Zoorob, “Synthesis and Antimicrobial Evaluation of Some Novel 5-Phenyl-5H-thiazolo[4,3-b][1,3,4]thiadiazole Systems,” Journal of Heterocyclic Chemistry 54, no. 4 (2017): 2360–6.
   Web of Science ®Google Scholar
• T. Wang, W. Miao, S. Wu, G. Bing, X. Zhang, Z. Qin, H. Yu, X. Qin, and J. Fang, “Synthesis, crystal structure and herbicidal activities of 2-cyanoacrylates containing 1,3,4-thiadiazole moieties,” Chinese Journal of Chemistry 29, (2011): 959–67.
   Web of Science ®Google Scholar
• A. R. Sayed, “Synthesis of Novel Thiadiazoles and Bis-Thiadiazoles from Carbonothioic Dihydrazide,” Tetrahedron Letters 51, no. 34 (2010): 4490–3.
   Web of Science ®Google Scholar
• A. Abdel-Aziem, “An Efficient and Simple Synthesis of 2, 3-dihydro-1, 3, 4-thiadiazoles, Pyrazoles and Coumarins Containing Benzofuran moiety using both Conventional and Grinding Methods,” International Journal of Pharmacy and Pharmaceutical Sciences 7, (2015): 61–8.
   Google Scholar
• Y.-H. Miao, Y.-H. Hu, J. Yang, T. Liu, J. Sun, and X.-J. Wang, “Natural Source, Bioactivity and Synthesis of Benzofuran Derivatives,” RSC Advances 9, no. 47 (2019): 27510–40.
   PubMed Web of Science ®Google Scholar
• H. Khanam and Shamsuzzaman, “Bioactive Benzofuran Derivatives: A Review,” European Journal of Medicinal Chemistry 97, (2015): 483–504
   PubMed Web of Science ®Google Scholar
• G. Khodarahmi, P. Asadi, F. Hassanzadeh, and E. Khodarahmi, “Benzofuran as a Promising Scaffold for the Synthesis of Antimicrobial and Antibreast Cancer Agents: A Review,” Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences 20, no. 11 (2015): 1094–104.
   PubMed Web of Science ®Google Scholar
• A. Gaspar, M. J. Matos, J. Garrido, E. Uriarte, and F. Borges, “Chromone: A Valid Scaffold in Medicinal Chemistry,” Chemical Reviews 114, no. 9 (2014): 4960–92.
   PubMed Web of Science ®Google Scholar
• N. F. L. Machado and M. P. M. Marques, “Bioactive Chromone Derivatives – Structural Diversity,” Current Bioactive Compounds 6, no. 2 (2010): 76–89.
   Google Scholar
• Y.-D. Duan, Y.-Y. Jiang, F.-X. Guo, L.-X. Chen, L.-L. Xu, W. Zhang, and B. Liu, “The Antitumor Activity of Naturally Occurring Chromones: A Review,” Fitoterapia 135, (2019): 114–29.
   PubMed Web of Science ®Google Scholar
• Zheng Li, Jin-Lan Yu, Jing-Ya Yang, Wei Zhu, Yan-Long Zhao, Yu-Lin Xing, and Xi-Cun Wang, “Solvent-Free Synthesis of 2-Amino-5-aryloxymenthyl1-1,3,4-thiadiazoles and Their Coumarin or Benzofuran Bis-Heterocyclic Derivatives,” Phosphorus, Sulfur, and Silicon and the Related Elements 181, no. 1 (2006): 183–90.
   Web of Science ®Google Scholar
• A. Schonberg and A. Sina, "Khellin and Allied Compounds," Journal of the American Chemical Society 72, (1950): 1611–5.
   Web of Science ®Google Scholar
• J. B. Baell, R. W. Gable, A. J. Harvey, N. Toovey, T. Herzog, W. Hansel, and H. Wulff, “Khellinone Derivatives as Blockers of the Voltage-Gated Potassium Channel Kv1.3: synthesis and Immunosuppressive Activity,” Journal of Medicinal Chemistry 47, no. 9 (2004): 2326–36.
   PubMed Web of Science ®Google Scholar
• Alexander Schönberg, Nasry Badran, and Nicolas A. Starkowsky, “Furo-Chromones and -Coumarins. VII. Degradation of Visnagin, Khellin and Related Substances; Experiments with Chromic Acid and Hydrogen Peroxide; and a Synthesis of Eugenitin,” Journal of the American Chemical Society 75, no. 20 (1953): 4992–5.
   Web of Science ®Google Scholar
• S. A. Abdelatef, M. T. El-Saadi, N. H. Amin, A. H. Abdelazeem, H. A. Omar, and K. R. A. Abdellatif, “Design, Synthesis and Anticancer Evaluation of Novel Spirobenzo[h]Chromene and Spirochromane Derivatives with Dual EGFR and B-RAF Inhibitory Activities,” European Journal of Medicinal Chemistry 150, (2018): 567–78.
   PubMed Web of Science ®Google Scholar
• D. L. Klayman, J. F. Bartosevich, T. S. Griffin, C. J. Mason, and J. P. Scovill, “2-Acetylpyridine Thiosemicarbazones. 1. A New Class of Potential Antimalarial Agents,” Journal of Medicinal Chemistry 22, no. 7 (1979): 855–62.
   PubMed Web of Science ®Google Scholar
• Abdou O. Abdelhamid, Sobhi M. Gomha, Nadia A. Abdelrehem, Ahmed M. Shalaby, and Sahar M. Kandeel, “Synthesis and Biological Evaluation of Some Novel Thiadiazole-Benzofuran Hybrids as Potential Antitumor Agents,” Synthetic Communications 48, no. 6 (2018): 677–84.
   Web of Science ®Google Scholar
• A. O. Abdelhamid, Z. H. Ismail, and A. Abdel-Aziem, “Reactions with Hydrazonoyl Halides 58 : Synthesis of 2,3-dihydro-1,3,4-thiadiazoles,” Phosphorus, Sulphur and Silicone and the Related Elements 183, (2008): 1–11.
   Web of Science ®Google Scholar
• A. S. Shawali and A. Osman, “Synthesis and Reactions of Phenylcarbamoylarylhydrazidic Chlorides,” Tetrahedron 27, no. 12 (1971): 2517–28.
   Web of Science ®Google Scholar
• A. O. Abdelhamid, F. A. Attaby, M. Y. Zaki, “eactions with 2 (thiocyanatoacetyl) and 2-(selenacyanoacetyl)-2′ benzofuran. Synthesis of some new thiadiazoline, selenadiazoline, thiadiazolo[2,3-b]quinazopline and arylazothiazole derivatives,” Phosphorus Sulfur Silicon and the Related Elements 53 (1990): 403–10.
   Google Scholar
• A. M. Asiri, A. O. Al-Youbi, M. E. M. Zayed, and S. W. Ng, “1-Chloro-1-[(4-meth-oxy-phen-yl)hydrazinyl-idene]propan-2-one,” Acta Crystallographica Section E, Structure Reports Online 67, no. Pt 8 (2011): o1961.
   PubMedGoogle Scholar
• A. M. Asiri, A. O. Al-Youbi, M. E. M. Zayed, and S. W. Ng, “ 1-Chloro-1-[(4-methyl-phen-yl)hydrazinyl-idene]propan-2-one,”Acta Crystallographica Section E Structure Reports Online 67, no. Pt 8 (2011): o1964.
   PubMedGoogle Scholar
• N. F. Eweiss and A. Osman, “Synthesis of Heterocycles. Part II. New Routes to Acetylthiadiazolines and Alkylazothiazoles,” Journal of Heterocyclic Chemistry 17, no. 8 (1980): 1713–7.
   Web of Science ®Google Scholar
• A. S. Shawali and A. Osman, “Reaction of Dimethylphenacylsulfonium Bromide with N -Nitrosoacetarylamides and Reactions of the Products with Nucleophiles,” Bulletin of the Chemical Society of Japan 49, no. 1 (1976): 321–4.
   Web of Science ®Google Scholar
• R. G. Dubenko and E. F. Gorbenko, “Substituted Glyoxalic Acids. XI. Synthesis of Arylhydrazones of Acid Chlorides of Substituted Glyoxalic Acid and Reactions with Amines and Hydrazine,” Zh. Org. Khim. 4, (1968): 634–638.
   Google Scholar
• A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paull, D. Vistica, C. Hose, J. Langley, P. Cronise, and A. J. Vaigro-Wolff, “Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines,” Journal of the National Cancer Institute 83, no. 11 (1991): 757–66.
   PubMed Web of Science ®Google Scholar
• R. H. Shoemaker, “The NCI60 Human Tumour Cell Line Anticancer Drug Screen,” Nature Reviews. Cancer 6, no. 10 (2006): 813–23.
   PubMed Web of Science ®Google Scholar
• M. R. Boyd and K. D. Paull, “Some Practical Considerations and Applications of the National Cancer Institute In Vitro Anticancer Drug Discovery Screen,” Drug Development Research 34, no. 2 (1995): 91–109.
   Web of Science ®Google Scholar